Mejait A, Roux C, Soret M, Larrey E, et al. Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival. Clin Res Hepatol Gastroenterol 2024;48:102282.
PMID: 38191073